Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus

2015 ◽  
Vol 148 (5) ◽  
pp. 1035-1058.e3 ◽  
Author(s):  
Brian Bressler ◽  
John K. Marshall ◽  
Charles N. Bernstein ◽  
Alain Bitton ◽  
Jennifer Jones ◽  
...  
2015 ◽  
Vol 29 (6) ◽  
pp. 294-296 ◽  
Author(s):  
A Hillary Steinhart ◽  
Aida Fernandes

A series of clinical practice guidelines were recently developed by the Canadian Association of Gastroenterology (CAG) to provide clinicians with recommendations for the medical management of nonhospitalized ulcerative colitis (UC) patients. These guidelines were developed, reviewed and agreed on by expert clinicians and methodologists. Following the finalization of the guidelines, a group of patients with UC as well as several inflammatory bowel disease clinicians, were brought together for a half-day workshop to provide feedback from the patient perspective. At the workshop, the guideline development process was described and the guidelines were reviewed to ensure comprehension. Patients then had the opportunity to provide their insight to the relevance of the guideline development process and the content of the guidelines as it related to their personal experiences with UC. The patient group believed that, although the new guidelines will be a tremendous resource for the health care provider community, a more ‘lay-friendly’ version would better facilitate dialogue between patients and their health care practitioners. The importance of the patient/physician relationship is paramount when making decisions regarding treatment plans, in which patient preferences play a key role in determining the most appropriate therapy and dosing regimen, which, in turn, impact the likelihood of adherence to the treatment plan. It was also believed that quality of life issues were not fully addressed in the guidelines. Much could be learned from shared experiences and coping strategies that would empower patients to take charge of their health and become equal partners with their care providers.


2021 ◽  
Vol 160 (7) ◽  
pp. 2496-2508 ◽  
Author(s):  
Joseph D. Feuerstein ◽  
Edith Y. Ho ◽  
Eugenia Shmidt ◽  
Harminder Singh ◽  
Yngve Falck-Ytter ◽  
...  

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Stefan D. Holubar ◽  
Amy L. Lightner ◽  
Vitaliy Poylin ◽  
Jon D. Vogel ◽  
Wolfgang Gaertner ◽  
...  

2019 ◽  
Vol 156 (3) ◽  
pp. 748-764 ◽  
Author(s):  
Cynthia W. Ko ◽  
Siddharth Singh ◽  
Joseph D. Feuerstein ◽  
Corinna Falck-Ytter ◽  
Yngve Falck-Ytter ◽  
...  

2020 ◽  
Vol 158 (5) ◽  
pp. 1450-1461 ◽  
Author(s):  
Joseph D. Feuerstein ◽  
Kim L. Isaacs ◽  
Yecheskel Schneider ◽  
Shazia Mehmood Siddique ◽  
Yngve Falck-Ytter ◽  
...  

2003 ◽  
Vol 1 (1) ◽  
pp. 72 ◽  

This article summarizes the NCCN clinical practice guidelines for screening for colorectal cancer. This guideline provides recommendations for appropriate screening and management of abnormal findings in groups at both average and high risk. In its deliberations, the Colorectal Cancer Screening Panel identified populations at high risk to include both patients with inflammatory bowel disease (ulcerative colitis and Crohn's disease) and individuals at risk because of a genetic predisposition. For the most recent version of the guidelines, please visit NCCN.org


Sign in / Sign up

Export Citation Format

Share Document